Skip to content

The NATINATI Study: A single intervention to compare the effects of hazelnut consumption on the acceptance and cardiovascular disease risk factors among Maori and European participants.

A single intervention to compare the effects of consuming 30g of hazelnuts per day for four weeks on the acceptance and cardiovascular disease risk factors among age-, sex- and BMI-matched Maori and European participants.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000230954
Enrollment
70
Registered
2011-03-03
Start date
2011-03-24
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Despite the public health recommendation to consume 30g of nuts per day, there is limited data investigating whether the recommended amount of nuts is considered acceptable to the consumer. One study reported that consuming the recommended 30 grams per day of nuts was found to be achievable and acceptable. The study population used in this research was largely European, therefore whether the results can be extrapolated to other ethics groups e.g. Maori, is unknown. In addition to measuring the acceptability of nuts, it is of equal importance to investigate the health properties of nuts. To date, there are five human intervention trials that have investigated the effect of hazelnut supplementation on plasma cholesterol levels. As the study population in the previous studies was largely European, it is of interest to compare the health effects of regular nut consumption in European and other ethnic group, i.e. Maori. The NATINATI study therefore aims to compare the acceptability of hazelnuts and the effects on blood lipids, lipoproteins, apolipoproteins, hs-CRP, glucose and insulin after consuming 30g of hazelnuts per day for four weeks among matched (age within 1 year, sex, BMI for 2 BMI points) Maori and European participants.

Interventions

This will be a single intervention, where participants will be asked to consume 30g of hazelnuts daily for four weeks. The study will be carried out to assess the effects of incorporating hazelnuts into the usual diet on blood lipids and lipoproteins, apolipoproteins, hs-CRP, glucose and insulin among Maori and European participants. This study will also examine the effects of repeated exposure to hazelnuts on participants' acceptance.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

The inclusion criteria are Maori and European males and females aged between 18 and 40 years of age. They should be in good health.

Exclusion criteria

The exclusion criteria are smokers. Pregnant or breastfeeding women. People who have asthma, food allergies or food aversions to nuts. People who have familial or secondary hyperlipidaemia or major chronic diseases such as cancer, heart disease or diabetes. People who are taking medication known to affect blood lipid levels.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026